KUALA LUMPUR, Sept 17 (Bernama) -- Arteris Inc, a provider of semiconductor technology for artificial intelligence (AI) applications, has expanded its multi-die portfolio to help semiconductor companies transition from monolithic system-on-chip (SoC) designs to chiplet-based architectures for AI, high-performance computing (HPC) and consumer electronics.
The company said its new FlexGen Multi-Die product extends network-on-chip (NoC) connectivity and data movement across die-to-die links, allowing multiple dies to operate as a unified architecture without requiring engineering teams to redesign how data moves through the system.
Arteris president and chief executive officer, K Charles Janac said multi-die architectures are becoming increasingly important as semiconductor systems expand beyond the boundaries of a single die.
According to the company in a statement, the new FlexGen Multi-Die product is designed for non-coherent AI and HPC architectures and complements Ncore Multi-Die, which supports cache-coherent systems.
FlexGen Multi-Die supports bidirectional transactions over a single Universal Chiplet Interconnect Express (UCIe) physical layer (PHY), reducing PHY area, power and input/output requirements by up to 50 per cent, the company said.
It also supports virtual channel link technology to improve utilisation of chiplet input/output resources and quality-of-service mechanisms to maintain throughput for high-priority traffic across shared die-to-die links.
Arteris said its broader multi-die portfolio also includes Magillem integration automation, which helps automate chiplet and multi-die integration, and Cycuity hardware security assurance for identifying vulnerabilities and verifying security requirements.
The company said the expanded portfolio provides semiconductor engineering teams with technologies covering data movement, system integration and security as they develop increasingly complex multi-die designs.
Arteris said the solutions are being used by customers transitioning existing architectures from single-die implementations to multi-die products, while the expanded portfolio is available to early access partners and strategic customers.
-- BERNAMA
Friday, 18 September 2026
Thursday, 17 September 2026
LRN LAUNCHES COMPLIANCE POLICY MANAGEMENT SOLUTION
KUALA LUMPUR, Sept 17 (Bernama) -- LRN Corporation, a global provider of ethics and compliance solutions, has launched Catalyst Policy, a compliance policy management solution integrated into LRN Catalyst platform.
In a statement, the company said Catalyst Policy enables organisations to manage policy creation, communication and adoption across geographies, languages and regulatory requirements, as artificial intelligence (AI) reshapes governance, risk and compliance requirements.
The solution was developed based on LRN’s work with clients managing global policy governance, including collaboration with Howden Group, a global insurance intermediary. The partnership drew on Howden’s experience in building compliance programmes and ethical cultures.
LRN Chief Executive Officer, Bob Lemmond said Howden’s experience had helped shape Catalyst Policy around the needs of global ethics and compliance teams.
Meanwhile, Howden Group Head of Compliance, Ian Jacob said effective policy lifecycle management was essential to reducing risk, meeting regulatory obligations and ensuring employees understood workplace conduct expectations.
LRN said organisations face growing policy complexity as regulatory requirements, business risks and the deployment of AI-related policies and governance continue to expand, increasing the need for clear oversight, accountability and audit readiness.
Catalyst Policy enables organisations to manage policies through a centralised model, replacing fragmented repositories and manual review and translation processes. Its features include in-platform redlining and track changes such as AI-assisted translations with human review; scoped access for external auditors and reviewers; and evergreen links and an immutable repository.
The solution also connects policy governance with attestations, training, policy access, analytics and behavioural insights within the LRN Catalyst platform.
LRN said its research on ethics and compliance programme effectiveness shows that high-impact programmes integrate data and analytics across ethics and compliance initiatives into day-to-day management. Catalyst Policy forms part of the company’s broader approach to connected governance, behavioural insights and data-driven compliance management.
-- BERNAMA
In a statement, the company said Catalyst Policy enables organisations to manage policy creation, communication and adoption across geographies, languages and regulatory requirements, as artificial intelligence (AI) reshapes governance, risk and compliance requirements.
The solution was developed based on LRN’s work with clients managing global policy governance, including collaboration with Howden Group, a global insurance intermediary. The partnership drew on Howden’s experience in building compliance programmes and ethical cultures.
LRN Chief Executive Officer, Bob Lemmond said Howden’s experience had helped shape Catalyst Policy around the needs of global ethics and compliance teams.
Meanwhile, Howden Group Head of Compliance, Ian Jacob said effective policy lifecycle management was essential to reducing risk, meeting regulatory obligations and ensuring employees understood workplace conduct expectations.
LRN said organisations face growing policy complexity as regulatory requirements, business risks and the deployment of AI-related policies and governance continue to expand, increasing the need for clear oversight, accountability and audit readiness.
Catalyst Policy enables organisations to manage policies through a centralised model, replacing fragmented repositories and manual review and translation processes. Its features include in-platform redlining and track changes such as AI-assisted translations with human review; scoped access for external auditors and reviewers; and evergreen links and an immutable repository.
The solution also connects policy governance with attestations, training, policy access, analytics and behavioural insights within the LRN Catalyst platform.
LRN said its research on ethics and compliance programme effectiveness shows that high-impact programmes integrate data and analytics across ethics and compliance initiatives into day-to-day management. Catalyst Policy forms part of the company’s broader approach to connected governance, behavioural insights and data-driven compliance management.
-- BERNAMA
JUMIO EXPANDS REUSABLE IDENTITY SOLUTION IN APAC
 |
| Jumio Extends True Reusable Identity to APAC with selfie.DONE™, Powered by Global Identity Graph |
KUALA LUMPUR, Sept 17 (Bernama) -- Jumio, an artificial intelligence (AI)-powered identity intelligence provider, has launched its reusable identity solution, selfie.DONE, across the Asia-Pacific (APAC) region as part of its global rollout.
The company said the solution enables businesses to recognise enrolled users through a selfie without requiring an identity document at the start of every onboarding process, with document verification retained for users who cannot be confidently recognised or present elevated risk.
Jumio president and chief product and technology officer, Bala Kumar said the APAC launch marked a shift from point-in-time verification towards continuous identity intelligence, enabling organisations to recognise trusted users while maintaining appropriate risk and compliance controls.
In a statement, the company said deployments of selfie.DONE have recorded a 20 per cent increase in verification completion rates, with up to 60 per cent of users completing verification without submitting an identity document.
Unlike identity wallets or networks limited to affiliated businesses, Jumio said its solution uses a global identity graph containing over 75 million legitimate and fraudulent identities, which grows by approximately 85,000 identities daily.
The company said the connected identity intelligence enables businesses to recognise users previously verified elsewhere while conducting fresh risk assessments for each transaction.
Selfie.DONE is being introduced in APAC following launches in Latin America and North America. Jumio said the solution is aimed at organisations including financial services firms, gaming platforms and sharing-economy businesses.
Jumio said the APAC expansion comes as companies in the region explore more streamlined know-your-customer (KYC) processes and seek to reduce onboarding friction while meeting regulatory requirements.
Nimbura, a Malaysia-based licensed digital lender, said the technology could help improve customer conversion in digital lending while maintaining security and compliance.
-- BERNAMA
D-WAVE TO HOST QUBITS ASIA 2026 IN SEOUL ON OCT 28
KUALA LUMPUR, Sept 17 (Bernama) -- D-Wave Quantum Inc (D-Wave), a quantum computing company providing both annealing and gate-model systems, software and services, will host Qubits Asia 2026: Quantum Realized, a full-day quantum computing user conference, on Oct 28 in Seoul.
Focused on the growing impact of quantum computing across the Asia-Pacific (APAC) region, the event will spotlight production applications addressing complex business challenges and research advancing scientific discovery, as well as the latest developments in D-Wave’s annealing and gate-model technologies.
D-Wave in a statement said the conference will bring together its executives, customers, researchers and industry leaders to share lessons from real-world implementations, exchange best practices and explore opportunities to accelerate quantum computing adoption across APAC.
“Countries including Japan, Singapore, South Korea, and Taiwan are moving decisively to establish global leadership in quantum computing, and D-Wave is helping turn that ambition into measurable results today.
“Qubits Asia will demonstrate what leadership looks like in practice by bringing together customers, researchers and industry leaders to accelerate commercial adoption, advance scientific discovery and expand the impact of quantum computing across the region,” said D-Wave Chief Executive Officer (CEO), Dr Alan Baratz.
Qubits Asia 2026 comes amid continued momentum for D-Wave across APAC, marked by growing customer adoption, strategic collaborations and commercial and research initiatives spanning network optimisation, artificial intelligence (AI) and machine learning, materials science, and semiconductor manufacturing as well as port operations.
Conference highlights include D-Wave CEO Dr Baratz and Chief Development Officer Dr Trevor Lanting sharing updates on the company’s annealing and gate-model quantum computing technologies, commercial applications and advances in quantum AI.
In addition, NTT DOCOMO researcher Shuichi Fukuda will discuss the Japanese mobile operator’s two D-Wave-powered quantum computing applications now operating in production and the resulting improvements in network efficiency and performance, while LG CNS Consulting Manager Wanki Cho will discuss the use of D-Wave technology to enhance 3D CT imaging for manufacturing inspections.
-- BERNAMA
Focused on the growing impact of quantum computing across the Asia-Pacific (APAC) region, the event will spotlight production applications addressing complex business challenges and research advancing scientific discovery, as well as the latest developments in D-Wave’s annealing and gate-model technologies.
D-Wave in a statement said the conference will bring together its executives, customers, researchers and industry leaders to share lessons from real-world implementations, exchange best practices and explore opportunities to accelerate quantum computing adoption across APAC.
“Countries including Japan, Singapore, South Korea, and Taiwan are moving decisively to establish global leadership in quantum computing, and D-Wave is helping turn that ambition into measurable results today.
“Qubits Asia will demonstrate what leadership looks like in practice by bringing together customers, researchers and industry leaders to accelerate commercial adoption, advance scientific discovery and expand the impact of quantum computing across the region,” said D-Wave Chief Executive Officer (CEO), Dr Alan Baratz.
Qubits Asia 2026 comes amid continued momentum for D-Wave across APAC, marked by growing customer adoption, strategic collaborations and commercial and research initiatives spanning network optimisation, artificial intelligence (AI) and machine learning, materials science, and semiconductor manufacturing as well as port operations.
Conference highlights include D-Wave CEO Dr Baratz and Chief Development Officer Dr Trevor Lanting sharing updates on the company’s annealing and gate-model quantum computing technologies, commercial applications and advances in quantum AI.
In addition, NTT DOCOMO researcher Shuichi Fukuda will discuss the Japanese mobile operator’s two D-Wave-powered quantum computing applications now operating in production and the resulting improvements in network efficiency and performance, while LG CNS Consulting Manager Wanki Cho will discuss the use of D-Wave technology to enhance 3D CT imaging for manufacturing inspections.
-- BERNAMA
Monday, 14 September 2026
MONEYHERO REPORTS US$15.8 MLN Q2 REVENUE
KUALA LUMPUR, Sept 14 (Bernama) -- MoneyHero Limited (MoneyHero), a technology- and artificial intelligence (AI)-powered personal finance aggregation and comparison platform, reported revenue of US$15.8 million in the second quarter (Q2) of 2026, down 13 per cent year-over-year (YoY). (US$1=RM4.06)
The company posted a net loss of US$1.2 million for Q2, compared with a net profit of US$0.2 million a year earlier, mainly due to foreign exchange (FX) differences, which swung from a US$3.0 million gain to a US$0.1 million loss.
In a statement, the company said adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) loss narrowed 17 per cent YoY to US$1.6 million.
MoneyHero said total transaction value remained flat YoY at US$20.9 million in Q2, while cash rewards provided to platform users increased by 77 per cent YoY to US$5.1 million. The increase in cash rewards formed part of its strategy to attract higher-intent customers, with Hong Kong and Singapore remaining its core markets.
Revenue from higher-margin Wealth and Insurance products rose to US$4.7 million in Q2, accounting for 30 per cent of total revenue, compared with 27 per cent in the same quarter last year. Revenue from Credit Cards declined 18 per cent YoY to US$8.9 million.
Cost of revenue fell 17 per cent YoY to US$7.6 million in Q2, accounting for 48 per cent of revenue, while combined cost of revenue, advertising and marketing, technology, employee benefit, and general administrative and other operating expenses declined 12 per cent to US$18.2 million.
Technology costs fell 50 per cent YoY to US$0.5 million, which MoneyHero attributed to continued platform consolidation and artificial intelligence (AI)-driven automation of engineering and operational workflows.
During Q2, MoneyHero advanced several partner-led initiatives and broadened its product offerings. In Singapore, it secured exclusive partnerships with two of the country’s largest retail banks, while in Taiwan it launched a KOL pilot with a local bank to test a more targeted, partner-led customer acquisition model. In Hong Kong, it is broadening its online life insurance offering to include critical illness coverage.
MoneyHero ended the quarter with a healthy, debt-free balance sheet, with US$28.2 million in cash and cash equivalents and US$32.6 million in net current assets as at June 30. Its MoneyHero Group Members base also grew 17 per cent YoY to 10.1 million.
Looking ahead, MoneyHero said it remains focused on converting structural efficiency gains into full-year adjusted EBITDA improvement while advancing product expansion, AI initiatives and other strategic growth programmes.
-- BERNAMA
The company posted a net loss of US$1.2 million for Q2, compared with a net profit of US$0.2 million a year earlier, mainly due to foreign exchange (FX) differences, which swung from a US$3.0 million gain to a US$0.1 million loss.
In a statement, the company said adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) loss narrowed 17 per cent YoY to US$1.6 million.
MoneyHero said total transaction value remained flat YoY at US$20.9 million in Q2, while cash rewards provided to platform users increased by 77 per cent YoY to US$5.1 million. The increase in cash rewards formed part of its strategy to attract higher-intent customers, with Hong Kong and Singapore remaining its core markets.
Revenue from higher-margin Wealth and Insurance products rose to US$4.7 million in Q2, accounting for 30 per cent of total revenue, compared with 27 per cent in the same quarter last year. Revenue from Credit Cards declined 18 per cent YoY to US$8.9 million.
Cost of revenue fell 17 per cent YoY to US$7.6 million in Q2, accounting for 48 per cent of revenue, while combined cost of revenue, advertising and marketing, technology, employee benefit, and general administrative and other operating expenses declined 12 per cent to US$18.2 million.
Technology costs fell 50 per cent YoY to US$0.5 million, which MoneyHero attributed to continued platform consolidation and artificial intelligence (AI)-driven automation of engineering and operational workflows.
During Q2, MoneyHero advanced several partner-led initiatives and broadened its product offerings. In Singapore, it secured exclusive partnerships with two of the country’s largest retail banks, while in Taiwan it launched a KOL pilot with a local bank to test a more targeted, partner-led customer acquisition model. In Hong Kong, it is broadening its online life insurance offering to include critical illness coverage.
MoneyHero ended the quarter with a healthy, debt-free balance sheet, with US$28.2 million in cash and cash equivalents and US$32.6 million in net current assets as at June 30. Its MoneyHero Group Members base also grew 17 per cent YoY to 10.1 million.
Looking ahead, MoneyHero said it remains focused on converting structural efficiency gains into full-year adjusted EBITDA improvement while advancing product expansion, AI initiatives and other strategic growth programmes.
-- BERNAMA
Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting Ceremony
WALNUT CREEK, Calif. and SHANGHAI, Sept 10 (Bernama-GLOBE NEWSWIRE) -- Dark Horse Consulting Group (DHCG) marked the opening of its Shanghai office with a ribbon cutting ceremony celebrating Dark Horse Consulting China. The event brought together DHCG leadership, “Shanghai Center of Biomedicine Development”, “China leading CDMO and CRO companies”, and invited guests from across the region's life sciences community. Anthony Davies, Ph.D., Founder and CEO, led the ceremony, joined by John Ng, MBA, General Manager, DHC Asia Pacific, and Kang Liu, Ph.D., Senior Director, Head of China. The ribbon cutting ceremony is jointly performed by Mr. Zhang Hua, Deputy Director at Shanghai Center of Biomedicine Development, Anthony Davies, Founder and CEO at DHCG and John Ng, GM APAC at DHCG.
DHCG announced the formation of Dark Horse Consulting China in August 2026, together with Kang Liu's appointment to lead it. The practice was established to help biotherapeutic developers leverage China's advanced CDMO and CRO infrastructure, its streamlined regulatory pathways to first-in-human (FIH), and its growing role as a hub for globally relevant clinical data. China's life sciences sector is at an inflection point. Its manufacturing and contract research infrastructure now rivals global standards, its regulatory frameworks continue to mature, and the Investigator Initiated Trial (IIT) pathway offers developers a cost-effective route to FIH data.
Those advantages are driving a fundamental shift in the global biopharma landscape. Lower clinical costs and faster timelines have made China IITs a serious consideration for innovative companies, supported by an ecosystem in which leading CDMOs match their global counterparts, intellectual property enforcement is held to international standards, and co-development agreements with western partners have become routine. Under Decree 818, studies are restricted to Grade A tertiary hospitals, a measure that has strengthened data quality, and western regulators are increasingly recognizing the validity of IIT-generated data.
“Standing in Shanghai with our partners makes concrete something we have believed for years: biotech is a truly global industry, and China is a core consideration for western developers rather than an afterthought. Dark Horse Consulting China is how we make that opportunity navigable for our clients," said Anthony Davies, Ph.D., Founder and CEO of Dark Horse Consulting Group.
Dark Horse Consulting China guides clients through every stage of the IIT process, from assessing strategic fit and building a regulatory strategy that works across frameworks, to CMC planning, CDMO and CRO selection, hospital and principal investigator selection, supply chain management, and strategy for fundraising and asset licensing.
“Today marks the beginning of the work, not the end of it. The opportunity to generate meaningful clinical data in China and to accelerate programs globally is real, and it is here now. DHCG China exists to make that path clear, strategic, and executable," said Kang Liu, Ph.D., Senior Director, Head of China at Dark Horse Consulting Group.
About Dark Horse Consulting Group
Dark Horse Consulting Group is a worldwide consulting organization with offices in North America, Europe, and APAC. Founded in 2014 to accelerate the development and delivery of cell and gene therapies through specialized expertise, the firm's focus has since expanded dramatically, with consulting team expertise now encompassing strategy, operations, Quality, regulatory affairs, manufacturing, modeling, supply chain, commercial launch, and business optimization across the biopharma landscape. DHCG provides white-glove client service grounded in rigorous scientific and technical expertise, from early discovery through commercial launch. The organization comprises three business units, DHC, BioTechLogic, and Converge Consulting, with Bruder Consulting & Venture Group forming a specialized Regenerative Medicine department within DHC. DHCG is currently expanding into the APAC region in 2026 through the acquisition of CJP Tokyo and the formation of Dark Horse Consulting China.
bd@darkhorseconsultinggroup.com
SOURCE: Dark Horse Consulting Group
--BERNAMA
Those advantages are driving a fundamental shift in the global biopharma landscape. Lower clinical costs and faster timelines have made China IITs a serious consideration for innovative companies, supported by an ecosystem in which leading CDMOs match their global counterparts, intellectual property enforcement is held to international standards, and co-development agreements with western partners have become routine. Under Decree 818, studies are restricted to Grade A tertiary hospitals, a measure that has strengthened data quality, and western regulators are increasingly recognizing the validity of IIT-generated data.
“Standing in Shanghai with our partners makes concrete something we have believed for years: biotech is a truly global industry, and China is a core consideration for western developers rather than an afterthought. Dark Horse Consulting China is how we make that opportunity navigable for our clients," said Anthony Davies, Ph.D., Founder and CEO of Dark Horse Consulting Group.
Dark Horse Consulting China guides clients through every stage of the IIT process, from assessing strategic fit and building a regulatory strategy that works across frameworks, to CMC planning, CDMO and CRO selection, hospital and principal investigator selection, supply chain management, and strategy for fundraising and asset licensing.
“Today marks the beginning of the work, not the end of it. The opportunity to generate meaningful clinical data in China and to accelerate programs globally is real, and it is here now. DHCG China exists to make that path clear, strategic, and executable," said Kang Liu, Ph.D., Senior Director, Head of China at Dark Horse Consulting Group.
About Dark Horse Consulting Group
Dark Horse Consulting Group is a worldwide consulting organization with offices in North America, Europe, and APAC. Founded in 2014 to accelerate the development and delivery of cell and gene therapies through specialized expertise, the firm's focus has since expanded dramatically, with consulting team expertise now encompassing strategy, operations, Quality, regulatory affairs, manufacturing, modeling, supply chain, commercial launch, and business optimization across the biopharma landscape. DHCG provides white-glove client service grounded in rigorous scientific and technical expertise, from early discovery through commercial launch. The organization comprises three business units, DHC, BioTechLogic, and Converge Consulting, with Bruder Consulting & Venture Group forming a specialized Regenerative Medicine department within DHC. DHCG is currently expanding into the APAC region in 2026 through the acquisition of CJP Tokyo and the formation of Dark Horse Consulting China.
bd@darkhorseconsultinggroup.com
SOURCE: Dark Horse Consulting Group
--BERNAMA
Thursday, 10 September 2026
AM BEST: REGULATORY INITIATIVES, ECONOMIC EXPANSION DRIVE MALAYSIA’S NON-LIFE GROWTH
KUALA LUMPUR, Sept 10 (Bernama) -- AM Best has maintained a stable outlook on Malaysia’s non-life insurance segment, citing regulatory initiatives and economic expansion, which are driving robust premium growth and increasing insurance penetration.
The stable outlook on Malaysia’s non-life segment is also supported by de-tariffication of motor and fire insurance, as well as measures curbing medical inflation. However, it remains vulnerable to developments in the external environment.
The Best’s Market Segment Report, “Market Segment Outlook: Malaysia Non-Life Insurance”, stated that motor and fire insurance anchor the market, together accounting for more than 65 per cent of total non-life premiums.
In a statement, the global credit rating agency said pricing has progressively shifted towards a more risk-based approach since phased liberalisation of tariffs for these lines began in July 2016.
Over time, AM Best expects de-tariffication to drive product innovation, improve service quality, align pricing with underlying risks and enhance market efficiency, although it may pressure underwriting margins over the intermediate term.
“Malaysia’s non-life insurers continue to maintain healthy underwriting profits through disciplined underwriting and effective pricing strategies, supporting the industry’s long-term sustainability,” said AM Best senior financial analyst, Sin Yee Chuah, adding that the segment remains poised for continued growth.
The rating agency added that Malaysia’s non-life segment reported an improved underwriting profit in 2025, with a healthy combined ratio in the low-to-mid-90 per cent range, reflecting sustained underwriting discipline that supported profitability.
Malaysia’s economy continues to be supported by resilient domestic demand, particularly household consumption and investment, while strong demand for electrical and electronics exports and continued investment in data centres provide additional support.
The report also noted that a pilot phase of the recently introduced RESET Strategy, which introduced a standardised base medical and health insurance/takaful plan with a co-payment feature, is targeted for the second half of 2026, with full rollout expected by early 2027.
In addition, climate change is projected to increase the frequency and severity of extreme weather events, presenting floods as a persistent tail risk for insurers and exposing the segment’s profitability to greater volatility.
-- BERNAMA
The stable outlook on Malaysia’s non-life segment is also supported by de-tariffication of motor and fire insurance, as well as measures curbing medical inflation. However, it remains vulnerable to developments in the external environment.
The Best’s Market Segment Report, “Market Segment Outlook: Malaysia Non-Life Insurance”, stated that motor and fire insurance anchor the market, together accounting for more than 65 per cent of total non-life premiums.
In a statement, the global credit rating agency said pricing has progressively shifted towards a more risk-based approach since phased liberalisation of tariffs for these lines began in July 2016.
Over time, AM Best expects de-tariffication to drive product innovation, improve service quality, align pricing with underlying risks and enhance market efficiency, although it may pressure underwriting margins over the intermediate term.
“Malaysia’s non-life insurers continue to maintain healthy underwriting profits through disciplined underwriting and effective pricing strategies, supporting the industry’s long-term sustainability,” said AM Best senior financial analyst, Sin Yee Chuah, adding that the segment remains poised for continued growth.
The rating agency added that Malaysia’s non-life segment reported an improved underwriting profit in 2025, with a healthy combined ratio in the low-to-mid-90 per cent range, reflecting sustained underwriting discipline that supported profitability.
Malaysia’s economy continues to be supported by resilient domestic demand, particularly household consumption and investment, while strong demand for electrical and electronics exports and continued investment in data centres provide additional support.
The report also noted that a pilot phase of the recently introduced RESET Strategy, which introduced a standardised base medical and health insurance/takaful plan with a co-payment feature, is targeted for the second half of 2026, with full rollout expected by early 2027.
In addition, climate change is projected to increase the frequency and severity of extreme weather events, presenting floods as a persistent tail risk for insurers and exposing the segment’s profitability to greater volatility.
-- BERNAMA
Subscribe to:
Posts (Atom)